Found: 40
Select item for more details and to access through your institution.
Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Diffusion-weighted MRI for uveal melanoma liver metastasis detection.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 6, p. 516, doi. 10.3390/cells8060516
- By:
- Publication type:
- Article
Quantitative CT Extent of Lung Damage in COVID-19 Pneumonia Is an Independent Risk Factor for Inpatient Mortality in a Population of Cancer Patients: A Prospective Study.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01560
- By:
- Publication type:
- Article
Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter study.
- Published in:
- Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00862-6
- By:
- Publication type:
- Article
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials.
- Published in:
- Cancer & Metastasis Reviews, 2013, v. 32, n. 1/2, p. 179, doi. 10.1007/s10555-012-9398-0
- By:
- Publication type:
- Article
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Circulating Tumor Cells, a Tremendous Prognostic Factor in Inflammatory Breast Cancer.
- Published in:
- 2015
- By:
- Publication type:
- editorial
Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-04322-5
- By:
- Publication type:
- Article
Plasma thymidine kinase 1 activity and outcome of ER+ HER2- metastatic breast cancer patients treated with palbociclib and endocrine therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Sacituzumab govitecan in metastatic triple-negative breast cancer patients treated at Institut Curie Hospitals: efficacy, safety, and impact of brain metastases.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 4, p. 572, doi. 10.1007/s12282-024-01565-7
- By:
- Publication type:
- Article
Biologie du processus métastatique.
- Published in:
- Médecine Sciences, 2012, v. 28, n. 1, p. 89, doi. 10.1051/medsci/2012281022
- By:
- Publication type:
- Article
Clinical utility of circulating tumor cells: an update.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 6, p. 1647, doi. 10.1002/1878-0261.12869
- By:
- Publication type:
- Article
Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types.
- Published in:
- Molecular Oncology, 2015, v. 9, n. 4, p. 783, doi. 10.1016/j.molonc.2014.12.003
- By:
- Publication type:
- Article
Circulating tumor cells: clinical validity and utility.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 3, p. 421, doi. 10.1007/s10147-017-1105-2
- By:
- Publication type:
- Article
ShallowHRD: detection of homologous recombination deficiency from shallow whole genome sequencing.
- Published in:
- Bioinformatics, 2020, v. 36, n. 12, p. 3888, doi. 10.1093/bioinformatics/btaa261
- By:
- Publication type:
- Article
Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma.
- Published in:
- Oncologist, 2016, v. 21, n. 3, p. 281, doi. 10.1634/theoncologist.2015-0501
- By:
- Publication type:
- Article
High seroprevalence but short‐lived immune response to SARS‐CoV‐2 infection in Paris.
- Published in:
- European Journal of Immunology, 2021, v. 51, n. 1, p. 180, doi. 10.1002/eji.202049058
- By:
- Publication type:
- Article
AMEERA-4: a randomized, preoperative window-of-opportunity study of amcenestrant versus letrozole in early breast cancer.
- Published in:
- Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-023-01740-2
- By:
- Publication type:
- Article
Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical Correlations of Programmed Cell Death Ligand 1 Status in Liquid and Standard Biopsies in Breast Cancer.
- Published in:
- Clinical Chemistry, 2020, v. 66, n. 8, p. 1093, doi. 10.1093/clinchem/hvaa121
- By:
- Publication type:
- Article
High-Accuracy Determination of Microsatellite Instability Compatible with Liquid Biopsies.
- Published in:
- Clinical Chemistry, 2020, v. 66, n. 4, p. 606, doi. 10.1093/clinchem/hvaa013
- By:
- Publication type:
- Article
Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR.
- Published in:
- Clinical Chemistry, 2018, v. 64, n. 2, p. 317, doi. 10.1373/clinchem.2017.272518
- By:
- Publication type:
- Article
Deciphering HER2-HER3 Dimerization at the Single CTC Level: A Microfluidic Approach.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1890, doi. 10.3390/cancers14081890
- By:
- Publication type:
- Article
Circulating Tumor Cells and Bevacizumab Pharmacokinetics during Neoadjuvant Treatment Combining Chemotherapy and Bevacizumab for Early Breast Cancer: Ancillary Analysis of the AVASTEM Trial.
- Published in:
- Cancers, 2021, v. 13, n. 1, p. 140, doi. 10.3390/cancers13010140
- By:
- Publication type:
- Article
Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Endothelial follicle-stimulating hormone receptor expression in invasive breast cancer and vascular remodeling at tumor periphery.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2015, v. 34, n. 1, p. 1, doi. 10.1186/S13046-015-0128-7
- By:
- Publication type:
- Article
Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00319-4
- By:
- Publication type:
- Article
Switch to Fulvestrant Upon Early Signs of Rising ESRl Mutations Improves Outcomes in HR-Positive Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2022, p. 16
- By:
- Publication type:
- Article
Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40569-9
- By:
- Publication type:
- Article
Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40569-9
- By:
- Publication type:
- Article
HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: A case report.
- Published in:
- International Journal of Cancer, 2017, v. 141, n. 8, p. 1667, doi. 10.1002/ijc.30863
- By:
- Publication type:
- Article
Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma.
- Published in:
- International Journal of Cancer, 2014, v. 134, n. 5, p. 1207, doi. 10.1002/ijc.28436
- By:
- Publication type:
- Article
Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study.
- Published in:
- International Journal of Breast Cancer, 2013, p. 1, doi. 10.1155/2013/130470
- By:
- Publication type:
- Article
Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
- Published in:
- 2016
- By:
- Publication type:
- Correction Notice
Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0144359
- By:
- Publication type:
- Article
Angiogenesis and tumor microenvironment: bevacizumab in the breast cancer model.
- Published in:
- Targeted Oncology, 2015, v. 10, n. 2, p. 189, doi. 10.1007/s11523-014-0334-9
- By:
- Publication type:
- Article
Trends in cancer-targeted antibody-drug conjugates.
- Published in:
- Targeted Oncology, 2014, v. 9, n. 1, p. 1, doi. 10.1007/s11523-013-0302-9
- By:
- Publication type:
- Article
Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).
- Published in:
- 2017
- By:
- Publication type:
- journal article